semaglutide and taste buds Does intervention with GLP-1 receptor agonist modulate perception of sweet in women with obesity: study protocol of a Weight-Loss Drug Semaglutide Making People

Personalized health assessment No obligation consultation Root cause analysis approach Semaglutide and tirzepatide are both used to support weight management, but they work differently and may suit different patient needs

Come prepared

Semaglutide is the GLP-1 receptor agonist that Novo sells as Ozempic and Wegovy

For GPs who have been prescribing semaglutide off-label to treat conditions such as obesity, while the medicines regulator acknowledges that it is a serious chronic disease that is challenging to manage, at this stage it is recommending that alternatives be considered as supply is expected to remain unstable for some time

B., Chidiac, J., Heldin, N